Short Interest in Aptorum Group Limited (NASDAQ:APM) Grows By 1,564.9%

Aptorum Group Limited (NASDAQ:APM) was the target of a significant increase in short interest in the month of December. As of December 31st, there was short interest totalling 184,800 shares, an increase of 1,564.9% from the December 15th total of 11,100 shares. Based on an average daily volume of 2,190,000 shares, the short-interest ratio is presently 0.1 days. Approximately 4.7% of the company’s shares are sold short.

Aptorum Group Trading Down 7.5 %

NASDAQ APM opened at $1.23 on Wednesday. Aptorum Group has a 12 month low of $0.46 and a 12 month high of $17.49. The stock has a 50-day simple moving average of $1.07 and a 200 day simple moving average of $2.13.

About Aptorum Group

Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A.